← Evidence map

ReviewCurrent medicinal chemistry2025

Design of PI3K-mTOR Dual Inhibitors for Ovarian Cancer: Are we on the Right Track?

Mangala Shenoy K et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38584538